Cargando…
Pramipexole prevents ischemic cell death via mitochondrial pathways in ischemic stroke
A dopamine D2 receptor agonist, pramipexole, has been found to elicit neuroprotection in patients with Parkinson’s disease and restless leg syndrome. Recent evidence has shown that pramipexole mediates its neuroprotection through mitochondria. Considering this, we examined the possible mitochondrial...
Autores principales: | Andrabi, Syed Suhail, Ali, Mubashshir, Tabassum, Heena, Parveen, Sabiha, Parvez, Suhel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Company of Biologists Ltd
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6737958/ https://www.ncbi.nlm.nih.gov/pubmed/31235613 http://dx.doi.org/10.1242/dmm.033860 |
Ejemplares similares
-
Melatonin and Ischemic Stroke: Mechanistic Roles and Action
por: Andrabi, Syed Suhail, et al.
Publicado: (2015) -
Cross-Talk Between Key Players in Patients with COVID-19 and Ischemic Stroke: A Review on Neurobiological Insight of the Pandemic
por: Kaushik, Pooja, et al.
Publicado: (2020) -
Progesterone induces neuroprotection following reperfusion-promoted mitochondrial dysfunction after focal cerebral ischemia in rats
por: Andrabi, Syed Suhail, et al.
Publicado: (2017) -
Dodging blood brain barrier with “nano” warriors: Novel strategy against ischemic stroke
por: Parvez, Suhel, et al.
Publicado: (2022) -
Nrf2/HO-1 mediates the neuroprotective effects of pramipexole by attenuating oxidative damage and mitochondrial perturbation after traumatic brain injury in rats
por: Salman, Mohd., et al.
Publicado: (2020)